respirerx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-Agent: *
Meta Tags
Title RespireRx Pharmaceuticals
Description 4/5/23 – RespireRx Pharmaceuticals Inc. Establishes Research Collaboration with University College CORPORATE Company Overview Board of Directors RespireRx Organization Structure Social Media Guidelines NEUROTRANSMISSION RESOLUTIONRX Cannabinoid Platform
Keywords N/A
Server Information
WebSite respirerx faviconrespirerx.com
Host IP 104.238.71.250
Location United States
Related Websites
Site Rank
More to Explore
respirerx.com Valuation
US$3,126,662
Last updated: 2023-05-10 21:51:06

respirerx.com has Semrush global rank of 3,385,177. respirerx.com has an estimated worth of US$ 3,126,662, based on its estimated Ads revenue. respirerx.com receives approximately 360,769 unique visitors each day. Its web server is located in United States, with IP address 104.238.71.250. According to SiteAdvisor, respirerx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,126,662
Daily Ads Revenue US$2,887
Monthly Ads Revenue US$86,585
Yearly Ads Revenue US$1,039,014
Daily Unique Visitors 24,052
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
respirerx.com. A 599 IP: 104.238.71.250
respirerx.com. NS 3600 NS Record: ns55.domaincontrol.com.
respirerx.com. NS 3600 NS Record: ns56.domaincontrol.com.
respirerx.com. MX 3600 MX Record: 0 respirerx-com.mail.protection.outlook.com.
respirerx.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
respirerx.com. TXT 3600 TXT Record: MS=ms77781519
HtmlToTextCheckTime:2023-05-10 21:51:06
CORPORATE Company Overview Board of Directors RespireRx Organization Structure Social Media Guidelines NEUROTRANSMISSION RESOLUTIONRX Cannabinoid Platform Summary Pharmaceutical Cannabinoids Obstructive Sleep Apnea Dronabinol for the Treatment of Obstructive Sleep Apnea Regulatory Process ENDEAVOURRX Neuromodulators Ampakines AMPAkine Platform Summary Lead Compounds Attention Deficit Hyperactivity Disorder (ADHD) Spinal Cord Injury (SCI) GABAkines GABAkines Platform Summary Background Epilepsy Pain PRODUCT PIPELINE INVESTORS Investor Contact SEC Reports News FAQs Presentations CONTACT RespireRx Pharmaceuticals Inc. is a biopharmaceutical company developing innovative and revolutionary treatments to combat disorders caused by disruption of neuronal signaling. In the News 4/5/23 – RespireRx Pharmaceuticals Inc. Establishes Research Collaboration with University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders April 5, 2023 j3ff1 4/3/23 – RespireRx
HTTP Headers
HTTP/1.1 200 OK
Accept-Ranges: bytes
Age: 78933
Content-Length: 58372
Content-Type: text/html; charset=UTF-8
Date: Tue, 02 Nov 2021 14:50:57 GMT
Vary: Accept-Encoding, User-Agent
X-Backend: local
X-Cache: cached
X-Cache-Hit: HIT
X-Cacheable: YES:Forced
X-Content-Type-Options: nosniff
X-Xss-Protection: 1; mode=block
respirerx.com Whois Information
Domain Name: RESPIRERX.COM
Registry Domain ID: 1954966368_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-25T17:04:43Z
Creation Date: 2015-08-24T14:34:21Z
Registry Expiry Date: 2023-08-24T14:34:21Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS55.DOMAINCONTROL.COM
Name Server: NS56.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-10-06T07:53:44Z <<<